Virpax Pharmaceuticals, Inc. (VRPX)

NASDAQ: VRPX · IEX Real-Time Price · USD

3.170

+0.020 (0.63%)

At close: Apr 24, 2024, 4:00 PM

3.100

-0.070 (-2.21%)

After-hours: Apr 24, 2024, 7:37 PM EDT

Virpax Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	9.14	19	36.84	0.05	0.04	0.05
Cash & Cash Equivalents	9.14	19	36.84	0.05	0.04	0.05
Cash Growth	-51.87%	-48.44%	67134.82%	31.92%	-14.13%	-
Other Current Assets	0.49	0.68	2.73	0.02	0.01	0.01
Total Current Assets	9.63	19.67	39.57	0.07	0.05	0.06
Other Long-Term Assets	0	0	0	0.39	0	0
Total Long-Term Assets	0	0	0	0.39	0	0
Total Assets	9.63	19.67	39.57	0.47	0.05	0.06
Accounts Payable	1.69	1.09	2.09	3.12	1.51	0.75
Current Debt	0	0	0	0.54	1.26	0.5
Other Current Liabilities	6	2	0	0	0	0
Total Current Liabilities	7.69	3.09	2.09	3.66	2.78	1.25
Long-Term Debt	0	0	0	1.02	0	0
Total Long-Term Liabilities	0	0	0	1.02	0	0
Total Liabilities	7.69	3.09	2.09	4.68	2.78	1.25
Total Debt	0	0	0	1.57	1.26	0.5
Debt Growth	-	-	-	23.81%	152.90%	-
Retained Earnings	-59.54	-44.35	-22.7	-10.65	-6.31	-3
Shareholders' Equity	1.93	16.58	37.48	-4.22	-2.73	-1.19
Net Cash / Debt	9.14	19	36.84	-1.51	-1.22	-0.45
Net Cash / Debt Growth	-51.87%	-48.44%	-	-	-	-
Net Cash Per Share	7.81	16.22	55.18	-4.86	-4.18	-1.59
Working Capital	1.93	16.58	37.48	-3.59	-2.73	-1.19
Book Value Per Share	1.65	14.16	56.14	-13.57	-9.33	-4.20

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).